A 2017 Pharma Serialisation Readiness Report focusing on industry readiness for the EU FMD deadlines, conducted by GS1 Ireland and ESP

In a recently published shared vision for product identification, the European Federation of Pharmaceutical Industries and Associations (EFPIA) supports the use of GS1 standards for the identification of products.

Advice and training from GS1 experts on implementing GS1 identification, barcoding and labelling standards such as GTINs, AIs and Data Matric Symbols for global serialisation requirements such as the EU falsified Medicines Directive (FMD).

Delegated Acts on safety features in the EU Falsified Medicines Directive (FMD) have been published and a compliance date set.

Draft directive issued for a unique identifier and an anti-tampering safety feature to prevent falsified medicine in the supply chain in Europe